# HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension

> **NCT07644364** · PHASE1 · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 64 (estimated)

## Conditions studied

- Elevated Blood Pressure
- Hypertension

## Interventions

- **DRUG:** HJB647
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07644364
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-02
- **Primary completion:** 2026-12-25
- **Final completion:** 2026-12-25
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644364, "HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*